Open Access 01-12-2022 | Bronchial Asthma | Research
Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma
Published in: Respiratory Research | Issue 1/2022
Login to get access